Interpreting tricyclic antidepressant measurements in urine in an emergency department setting: Comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis

Journal of Analytical Toxicology

Volumn 31, Issue 5, 2007, Pages 270-275

  Melanson, Stacy E F ^a   Lewandrowski, Elizabeth Lee ^b   Griggs, David A ^b   Flood, James G ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; DOXEPIN; IMIPRAMINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DRUG BLOOD LEVEL; EMERGENCY WARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; URINALYSIS;

EID: 34250378664     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.5.270     Document Type: Article

References (13)

1. www.aapcc.org/2004.htm, 2004 AAPCC TESS Report. Accessed December 2006.
2. J.G. Schwartz, I.L. Hurd, and J.J. Carnahan. Determination of tricyclic antidepressants for ED analysis. Am. J. Emerg. Med. 12: 513-516 (1994).
3. M.W. Linder and P. Keck. Standards of laboratory practice: antidepressant drug monitoring. Clin. Chem. 44: 1073-1084 (1998).
4. P.J. Orsulak, P.-K. Liu, and L.C. Akers. Antidepressant drugs. In The Clinical Toxicology Laboratory, L.M. Shaw and T.C. Kwong, Eds. AACC Press, Washington, D.C., 2001, pp 223-236.
5. A. Gee, C.A. McKay, and A.H.B. Wu. Tricyclic antidepressant (TCA) urine immunoassays: making better use of a test [abstract]. J. Toxicol. Clin. Toxicol. 50: 661 (2002).
6. J.M. Yang and K.B. Lewandrowski. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT). Clin. Chim. Acta 307: 27-32 (2001).
7. R. De La Torre, A. Domingo-Salvany, R. Badia, G. Gonzalez, D. McFarlane, L. San, and M. Torrens. Clinical evaluation of the Triage analytical device for drugs-of-abuse testing. Clin. Chem. 42: 1433-1438 (1996).
8. J.E. Phillips, S. Bogema, P. Fu, W. Furmaga, A.H.B. Wu, V. Zic, and C. Hammett-Stabler. Signify ER drug screen test evaluation: comparison to Triage drug of abuse panel plus tricyclic antidepressants. Clin. Chim. Acta 328: 31-38 (2003).
9. C. Tomaszewski, J. Runge, M. Gibbs, S. Colucciello, and M. Price. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity. J. Emerg. Med. 28: 389-394 (2005).
10. A.H.B. Wu, C. McKay, L.A. Broussard, R.S. Hoffman, T.C. Kwong, T.P. Moyer, E.M. Otten, S.L. Welch, and P. Wax. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendation for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin. Chem. 49: 357-379 (2003).
11. D.S. Chattergoon, Z. Verjee, M. Anderson, D. Johnson, M.A. McGuigan, G. Koren, and S. Ito. Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. Clin. Toxicol. 36: 109-113 (1998).
12. P.R. Puopolo, S.A. Volpicelli, D.M. Johnson, and J.G. Flood. Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection. Clin. Chem. 37: 2124-2130 (1991).
13. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Biomedical Publications, Foster City, CA, 2002, p 233.